Once-weekly injectable Wegovy plus lifestyle modification conferred a greater reduction in BMI than placebo among children ...

Novo Nordisk has reported a phase 3 weight-management win for Wegovy in children, with two out of five kids no longer ...

Novo Nordisk A/S (NYSE:NVO) looks to open a new growth avenue for its blockbuster obesity drug Wegovy by targeting the pediatric market. In the late-stage STEP Young trial, semaglutide (the active ...

Novo Nordisk (NYSE:NVO) said on Monday that 40. 4% of children with obesity who received once-weekly semaglutide in its phase 3 STEP Young trial achieved a body mass index below the obesity threshold ...

(HealthDay News) — From 2019 to 2026, there was an increase in glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescribing for children aged 8 to 11 years without diabetes but with obesity, ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

A study co-led by a Johns Hopkins Children's Center clinician-researcher shows that adding text messaging and other electronic feedback to traditional in-clinic health counseling for parents about ...

Although the number of US children under age 12 with obesity being prescribed the weight loss drugs Saxenda, Wegovy, and Zepbound remains low, the number is 310 times higher in June 2026 than ...

The share of children aged 8 to 11 years with obesity who were prescribed glucagon-like peptide-1 (GLP-1) receptor agonists rose 310-fold between January 2019 and June 2026, even though absolute use ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

Women who had a BMI trajectory for overweight or obesity during childhood are less likely to give birth beginning at age 25 ...

Although the number of U.S. children under age 12 with obesity who are prescribed the weight-loss drugs Saxenda, Wegovy and ...